Literature DB >> 7979295

Localization of azithromycin in Toxoplasma gondii-infected cells.

J C Schwab1, Y Cao, M R Slowik, K A Joiner.   

Abstract

Agents effective against intracellular pathogens must enter infected cells, crossing vacuolar membranes surrounding the organisms and then penetrating into the microbe and localizing to the microbial target site. We have characterized these parameters for azithromycin entry into Toxoplasma gondii-infected Chinese hamster ovary cells and murine macrophage-like J774 cells. Azithromycin uptake into infected host cells was concentrative and was dependent upon proton gradients. Subcellular fractionation of azithromycin-loaded infected CHO cells demonstrated > 95% intracellular drug in host cell lysosomes and cytosol, with < 5% associated with the parasite. Uptake of azithromycin into the T. gondii vacuole increased if parasites were coated with antibody prior to internalization by murine J774 cells, conditions which result in the formation of acidified phagolysosomes. No redistribution or retention of azithromycin in the parasite was observed when drug efflux from antibiotic-loaded infected CHO cells was monitored. Azithromycin entry into extracellular T. gondii was concentrative, was temperature and pH dependent, and was not different when azithromycin-sensitive and -resistant parasites were compared. These results demonstrate that azithromycin concentrates primarily in acidified compartments in parasites and host cells. The high concentration of azithromycin within these compartments may not be biologically relevant to inhibition of intracellular parasite growth by this agent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979295      PMCID: PMC284602          DOI: 10.1128/AAC.38.7.1620

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  35 in total

1.  Plaque assay of Toxoplasma on monolayers of chick embryo fibroblasts.

Authors:  S D CHAPARAS; R W SCHLESINGER
Journal:  Proc Soc Exp Biol Med       Date:  1959-11

2.  Lysosomes of Toxoplasma gondii and their possible relation to the host-cell penetration of toxoplasma parasites.

Authors:  R Norrby; L Lindholm; E Lycke
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

3.  Plasmodium falciparum: ATP/ADP transport across the parasitophorous vacuolar and plasma membranes.

Authors:  I Choi; R B Mikkelsen
Journal:  Exp Parasitol       Date:  1990-11       Impact factor: 2.011

4.  In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii.

Authors:  L Cantin; S Chamberland
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

5.  Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages.

Authors:  M B Carlier; B Scorneaux; A Zenebergh; J F Desnottes; P M Tulkens
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

Review 6.  Toxoplasmic encephalitis in AIDS.

Authors:  B J Luft; J S Remington
Journal:  Clin Infect Dis       Date:  1992-08       Impact factor: 9.079

7.  Inhibition of Toxoplasma gondii protein synthesis by azithromycin.

Authors:  J Blais; V Garneau; S Chamberland
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

8.  Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.

Authors:  F Derouin; R Almadany; F Chau; B Rouveix; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

9.  Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant.

Authors:  E R Pfefferkorn; R F Nothnagel; S E Borotz
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

10.  Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin.

Authors:  E R Pfefferkorn; S E Borotz
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

View more
  6 in total

1.  Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.

Authors:  Masami Sugie; Emiko Asakura; Ying Lan Zhao; Shoko Torita; Masayuki Nadai; Kenji Baba; Kiyoyuki Kitaichi; Kenji Takagi; Kenzo Takagi; Takaaki Hasegawa
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

2.  In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii.

Authors:  M E Fichera; M K Bhopale; D S Roos
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

3.  Acidocalcisomes in Toxoplasma gondii tachyzoites.

Authors:  S N Moreno; L Zhong
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

4.  Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.

Authors:  C J Beckers; D S Roos; R G Donald; B J Luft; J C Schwab; Y Cao; K A Joiner
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

Review 5.  The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites.

Authors:  Roberto Docampo; Silvia N J Moreno
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

6.  Role of extracellular calcium in in vitro uptake and intraphagocytic location of macrolides.

Authors:  E M Mtairag; H Abdelghaffar; C Douhet; M T Labro
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.